Filing Details
- Accession Number:
- 0000886163-14-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-14 20:04:49
- Reporting Period:
- 2014-02-12
- Filing Date:
- 2014-02-14
- Accepted Time:
- 2014-02-14 20:04:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208906 | L John Higgins | 11119 North Torrey Pines Road, Suite 200 La Jolla CA 92037 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-12 | 16,875 | $9.96 | 127,974 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-12 | 16,875 | $75.00 | 111,099 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-02-12 | 8,000 | $0.00 | 119,099 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2014-02-12 | 75,000 | $74.42 | 75,000 | $74.42 |
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2014-02-12 | 10,000 | $74.42 | 10,000 | $74.42 |
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2014-02-12 | 10,000 | $74.42 | 10,000 | $74.42 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-12 | 16,875 | $0.00 | 16,875 | $9.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 75,000 | 2024-02-12 | No | 4 | A | Direct | |
| 85,000 | 2024-02-12 | No | 4 | A | Direct | |
| 95,000 | 2024-02-12 | No | 4 | A | Direct | |
| 48,125 | 2020-02-15 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 11, 2013, in accordance with Rule 10b5-1.
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/12/14.
- The options vest upon satisfaction of certain performance criteria for the year ended December 31, 2015.
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/15/10.
Billionaire Hedge Funds
